Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced‐dose chemotherapy on Children's Oncology Group trial A2971 - Concepedia

Concepedia

Publication | Open Access

Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced‐dose chemotherapy on Children's Oncology Group trial A2971

DOI Full Paper Access

80

Citations

24

References

2012

Year

April Sorrell, Todd A. Alonzo, Joanne M. Hilden, Robert B. Gerbing, Thomas Loew, Lois Hathaway, Dorothy Barnard, Jeffrey W. Taub, Yaddanapudi Ravindranath, Franklin O. Smith,

Abstract

The COG A2971 trial reduced the chemotherapy dose and maintained survival to that achieved by the CCG 2891 trial in children who had myeloid leukemia associated with DS.

References

	Year	Citations

Page 1